Stay updated with breaking news from Davidb mcwilliams. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
JRM Construction Management Hosts 15-Year Anniversary Celebration rew-online.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from rew-online.com Daily Mail and Mail on Sunday newspapers.
STAFFORD, Texas (BUSINESS WIRE) Apr 10, 2021 Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the âCompanyâ), a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery, today presented a poster of the final 5 year GP2 Phase IIb clinical trial immune response data at the 2021 AACR Annual Meeting. Immune response is the primary mechanism of action for GP2 and is critical to developing dosing and booster treatment strategies that are designed to achieve and sustain peak immunity, as well as to prevent metastatic breast cancer recurrences. Figures 1-3 of Poster Presentation CT183 from 2021 AACR Annual Meeting Showing GP2 5 Year Immune Response Data (Graphic: Business Wire) ....